---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-22-000208"
form_type: "8-K"
ticker: "CRL"
cik: "0001100682"
company_name: "CHARLES RIVER LABORATORIES INTERNATIONAL, INC."
filed_at: "2022-02-16T23:59:59+00:00"
generated_at: "2026-06-27T07:22:03.658977+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Charles River Q4 rev $905.1M (+14.4%); reaffirms 2022 guidance with non-GAAP EPS $11.50-$11.75

## Summary
- Q4 GAAP EPS $2.67 vs $2.81 prior year (-5%); non-GAAP EPS $2.49 vs $2.39 (+4.2%).
- Full-year 2021 revenue $3.54B (+21.1%); organic growth 15.1%; non-GAAP EPS $10.32 (+26.9%).
- RMS segment organic growth 13.3%; DSA organic growth 6.7%; Manufacturing organic growth 21.2%.
- 2022 guidance: organic revenue growth 12.5-14.5%; non-GAAP EPS $11.50-$11.75; free cash flow ~$450M.
- GAAP net income Q4 $137.6M vs $143.2M; full-year $391M vs $364.3M.

## SEC filing metadata
- accession: 0001157523-22-000208
- form_type: 8-K
- ticker: CRL
- cik: 0001100682
- company_name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- filed_at: 2022-02-16T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1100682/000115752322000208/0001157523-22-000208-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1100682/000115752322000208/a52579962.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-22-000208
- JSON: https://secwatch.observer/filing/0001157523-22-000208.json
- Plain text: https://secwatch.observer/filing/0001157523-22-000208.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.